Journal of Nanobiotechnology

BMC has an evolving portfolio of some 300 peer-reviewed journals, sharing discoveries from research communities in science, technology, engineering and medicine. In 1999 we made high-quality research open to everyone who needed to access it – and in making the open-access model sustainable, we changed the world of academic publishing.

We are committed to continual innovation in research publishing to better support the needs of our communities, ensuring the integrity of the research we publish and championing the benefits of open research for all.

Aims and scope

Journal of Nanobiotechnology is an open-access peer-reviewed journal communicating scientific and technological advances in the fields of medicine and biology, with an emphasis in their interface with nanoscale sciences. The journal provides biomedical scientists and the international biotechnology business community with the latest developments in the growing field of Nanobiotechnology.

Open access

All articles published by Journal of Nanobiotechnology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Journal of Nanobiotechnology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Editors-in-Chief

Weibo Cai, University of Wisconsin - Madison, USA

Fernando Patolsky, University of Tel Aviv, Israel